EVOK

Evoke Pharma Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

EVOK price

Evoke Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment EVOK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals EVOK

Valuation

P/E

0.00

Sector 0.84

Industry -1.42

P/BV

0.00

Sector 1.82

Industry 1.25

P/Revenue (PSR)

Sector 1.48

Industry 2.13

EV/EBITDA

11.24

Sector -43.66

Industry -35.45

EV/EBIT

11.24

Sector -47.57

Industry -38.86

P/EBITDA

Sector -31.25

Industry -21.12

P/EBIT

Sector -42.58

Industry -25.59

P/Total Assets

Sector 0.82

Industry 0.70

P/Net Current Assets

0.00

Sector -23.77

Industry -59.56

P/Working Capital

0.00

Sector -3.73

Industry -1.93

EPS

-1.74

Sector -0.70

Industry -1.22

BVPS

1.12

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

97.02%

Sector 49.32%

Industry 49.70%

EBITDA Margin

-24.07%

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

-35.99%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-36.27%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.27

Sector 0.13

Industry 0.06

Profitability

ROE

-155.65%

Sector -24.30%

Industry -38.97%

ROA

-33.42%

Sector -24.50%

Industry -49.14%

ROIC

-77.48%

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.27

Sector 1.92

Industry 2.55

Net Debt / EBITDA

11.24

Sector -23.10

Industry -8.80

Net Debt / EBIT

11.24

Sector -17.84

Industry -36.75

Net Debt / Equity

-3.45

Sector -0.68

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.72

Industry -0.54

Equity/Assets

0.21

Sector 0.46

Industry 0.52

Liabilities/Assets

0.79

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

83.79%

Sector -

Industry -

5Y Earnings CAGR

-9.34%

Sector -

Industry -

Fundamentals EVOK

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
EVOK Evoke Pharma Inc.	$0.00	-100.00%	0.00%	0.00	0.00	-155.65%	-36.27%
LLY Eli Lilly and Compay	$1,249.76	56.65%	0.53%	42.13	33.21	78.84%	33.53%
SNY Sanofi	$39.81	-18.25%	4.38%	3.78	0.70	18.43%	14.25%
GSK GlaxoSmithKline PLC	$49.36	16.30%	3.58%	15.38	4.34	28.24%	14.54%
CRMD CorMedix Inc.	$7.48	-26.52%	0.00%	3.04	1.23	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$25.97	9.21%	0.00%	14.41	1.47	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$13.05	-9.04%	0.64%	29.37	2.65	9.03%	10.14%
JNJ Johnson & Johnson	$252.71	34.46%	2.08%	29.04	7.19	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$431.59	-3.26%	0.00%	48.53	8.32	17.15%	28.44%
NVS Novartis AG	$150.19	16.49%	2.05%	22.56	6.86	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$673.79	25.46%	0.27%	36.53	4.83	13.22%	15.04%
ABT Abbott Laboratories	$103.75	-16.91%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.84	0.14%	3.02%	23.20	2.39	10.29%	13.93%
CVS CVS Health Corporation	$91.15	14.82%	2.89%	24.09	1.47	6.12%	1.18%
BSX Boston Scientific Corp.	$44.56	-55.10%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$72.35	-38.50%	0.00%	16.36	4.79	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$556.87	-12.36%	0.00%	38.87	27.47	70.67%	25.03%
RMD ResMed Inc.	$239.43	-9.75%	1.03%	22.76	5.27	23.13%	26.94%
DHR Danaher Corporation	$224.14	8.20%	0.63%	40.42	3.08	7.61%	15.95%
HCA HCA Healthcare Inc.	$454.64	7.19%	0.66%	14.90	-31.76	-213.15%	8.77%
COHR Coherent Inc.	$240.39	106.61%	0.00%	57.23	4.10	7.16%	11.31%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

EVOK - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Evoke Pharma

Evoke Pharma Inc.

Average Investor10 user rating

4.0 (0 people)

United States

19 years

Founded: 2007

2013

Time since IPO - 13 years

5

Employees

Evoke Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $3.36 million.

The company employs approximately 5 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Evoke Pharma Inc. reported $14.42 million in revenue, generating net income of $-5.23 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker EVOK.

Market cap

Net worth

$3.36 million

$3,360,000.00

Assets

$15.65 million

$15,650,000.00

Total Shares Outstanding

3.00 million

3,000,000

Average Daily Trading Volume

$113.74 Thousand

$113,738.72

Sector

Health

Industry

Pharmaceutical Products

EVOK

EVOK revenue and profits

Financial Results EVOK

DRAG THE FRAME TO SEE MORE DATA

EVOK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76